SCHEMBL6146166

SCHEMBL6146166

CSC1(SC)CCOc2ccc(C(/C=C/c3ccc(C(=O)O)cc3)Cc3ccccc3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 7/20 0.44
RARB P10826 7/20 0.44
RARG P13631 7/20 0.44
STAT3 P40763 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
TRPV1 Q8NER1 1/20 0.34
RXRA P19793 2/20 0.34
RXRB P28702 1/20 0.34
SSTR5 P35346 2/20 0.34
TRPM8 Q7Z2W7 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6148053 1.00 RARA (0.44) RARARARBRARGSTAT3NPC1
SCHEMBL6148235 0.91 RARA (0.43) RARARARBRARGSTAT3NPC1
SCHEMBL6147365 0.91 RARA (0.43) RARARARBRARGSTAT3NPC1
SCHEMBL6146589 0.85 RARA (0.41) RARARARBRARGSTAT3NPC1
SCHEMBL6147891 0.79 RARB (0.69) RARARARBRARGNPC1RAB9A
SCHEMBL6147884 0.79 RARB (0.69) RARARARBRARGNPC1RAB9A
SCHEMBL4843938 0.78 RARA (0.41) RARARARBRARGSTAT3NPC1
SCHEMBL6143646 0.78 P4HTM (0.39) NPC1RAB9ASMN1; SMN2ALDH1A1HTT
SCHEMBL8458478 0.77 RXRA (0.54) RARARARBRARGRXRARXRB
SCHEMBL6145974 0.76 RARB (0.43) RARARARBRARGSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1280757-B1 NEW GAMMA SELECTIVE RETINOIDS HOFFMANN LA ROCHE (CH) 2005-08-17 EP claimed
US-20020026060-A1 RAR selective retinoid agonists F.HOFFMANN-LA ROCHE AG (CH) 2002-02-28 US claimed
EP-1280757-B1 NEW GAMMA SELECTIVE RETINOIDS HOFFMANN LA ROCHE (CH) 2005-08-17 EP disclosed
US-6603012-B2 RAR selective retinoid agonists HOFFMANN-LA ROCHE INC. 2003-08-05 US disclosed
US-20020026060-A1 RAR selective retinoid agonists F.HOFFMANN-LA ROCHE AG (CH) 2002-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020026060-A1 RAR selective retinoid agonists RARA, RARG, RARB RARA 1/4885RARB 3/4885RARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.